FDA Wants Broad Reimportation Enforcement Discretion
This article was originally published in The Pink Sheet Daily
The agency may seek an accelerated ruling in Vermont's lawsuit against FDA in light of decisions by other states to implement importation programs. FDA Acting Commissioner Crawford tells a conference in Geneva, Switzerland that a decision on imports should be left to the agency.
You may also be interested in...
Outstanding safety concerns are the sole reason for not yet allowing reimportation from Canada, Bush says during Q&A session with voters. By making drug imports a question of resources, he opens the door to approving some version of the practice.
A state website linked to a foreign PBM will be launched within a month, the governor announces. The plan will be limited to 100 brand name drugs.
Agency’s denial of Vermont’s petition to set up a “responsible” drug reimportation program leaves “no alternative” but to sue, the state says.